Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
4.550
+0.060 (1.34%)
At close: May 29, 2026, 4:00 PM EDT
4.560
+0.010 (0.22%)
After-hours: May 29, 2026, 7:55 PM EDT
Cybin Market Cap
Cybin has a market cap or net worth of $227.66 million as of May 29, 2026. Its market cap has increased by 69.63% in one year.
Market Cap
227.66M
Enterprise Value
32.53M
1-Year Change
69.63%
Ranking
Category
Stock Price
$4.55
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $227.66M, an increase of 149.92%. That is a compound annual growth rate of 17.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 227.66M | -44.23% |
| Dec 31, 2025 | 408.21M | 131.40% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Whitehawk Therapeutics | 236.27M |
| Nkarta | 236.10M |
| Voyager Therapeutics | 235.64M |
| Camp4 Therapeutics | 233.15M |
| Minerva Neurosciences | 232.94M |
| Atrium Therapeutics | 228.53M |
| Caribou Biosciences | 226.98M |
| Keros Therapeutics | 225.43M |